Loss of macrophage migration inhibitory factor impairs the growth properties of human HeLa cervical cancer cells

Cell Proliferation

Volumn 44, Issue 6, 2011, Pages 582-590

  Xiao, D Z ^a   Dai, B ^a   Chen, J ^a   Luo, Q ^a   Liu, X Y ^a   Lin, Q X ^a   Li, X H ^a   Huang, W ^a   Yu, X Y ^a  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; MACROPHAGE MIGRATION INHIBITION FACTOR; TUMOR NECROSIS FACTOR ALPHA; ANTINEOPLASTIC AGENT; ISOMERASE; MIF PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL ADHESION; CELL CYCLE CHECKPOINT; CELL PROLIFERATION; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DAMAGE; GENE EXPRESSION; GENE SILENCING; HELA CELL; HUMAN; HUMAN TISSUE; MACROPHAGE MIGRATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN FUNCTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UTERINE CERVIX CANCER; ANIMAL; CELL CYCLE; CELL MOTION; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; FEMALE; METABOLISM; MOLECULAR GENETICS; NUDE MOUSE; PATHOLOGY; STRUCTURE ACTIVITY RELATION; UTERINE CERVIX TUMOR;

MUS MUSCULUS;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL ADHESION; CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; DNA DAMAGE; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HELA CELLS; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR NECROSIS FACTOR-ALPHA; UTERINE CERVICAL NEOPLASMS;

EID: 84865982414     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2011.00787.x     Document Type: Article

References (47)

1. Paralkar V, Wistow G (1994) Cloning the human gene for macrophage migration inhibitory factor (MIF). Genomics 19, 48-51.
2. Kozak CA, Adamson MC, Buckler CE, Segovia L, Paralkar V, Wistow G (1995) Genomic cloning of mouse MIF (macrophage inhibitory factor) and genetic mapping of the human and mouse expressed gene and nine mouse pseudogenes. Genomics 27, 405-411.
3. Mitchell R, Bacher M, Bernhagen J, Pushkarskaya T, Seldin MF, Bucala R (1995) Cloning and characterization of the gene for mouse macrophage migration inhibitory factor (MIF). J. Immunol. 154, 3863-3870.
4. Larson DF, Horak K (2006) Macrophage migration inhibitory factor: controller of systemic inflammation. Crit. Care 10, 138.
5. Bloom BR, Bennett B (1966) Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153, 80-82.
6. David JR (1966) Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc. Natl. Acad. Sci. USA 56, 72-77.
7. Morand EF, Leech M, Bernhagen J (2006) MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis. Nat. Rev. Drug Discov. 5, 399-410.
8. Lin SG, Yu XY, Chen YX, Huang XR, Metz C, Bucala R et al. (2000) De novo expression of macrophage migration inhibitory factor in atherogenesis in rabbits. Circ. Res. 87, 1202-1208.
9. Kong YZ, Yu X, Tang JJ, Ouyang X, Huang XR, Fingerle-Rowson G et al. (2005) Macrophage migration inhibitory factor induces MMP-9 expression: implications for destabilization of human athero- sclerotic plaques. Atherosclerosis 178, 207-215.
10. Yu X, Lin SG, Huang XR, Bacher M, Leng L, Bucala R et al. (2007) Macrophage migration inhibitory factor induces MMP-9 expression in macrophages via the MEK-ERK MAP kinase pathway. J. Interferon Cytokine Res. 27, 103-109.
11. Zhong JC, Yu XY, Lin QX, Li XH, Huang XZ, Xiao DZ et al. (2008) Enhanced angiotensin converting enzyme 2 regulates the insulin/ Akt signalling pathway by blockade of macrophage migration inhibitory factor expression. Br. J. Pharmacol. 153, 66-74.
12. 2+ channel depression induced by macrophage migration inhibitory factor in atrial myocytes. J. Mol. Cell. Cardiol. 47, 586-594.
13. Liang JL, Xiao DZ, Liu XY, Lin QX, Shan ZX, Zhu JN et al. (2010) High glucose induces apoptosis in AC16 human cardiomyocytes via macrophage migration inhibitory factor and c-Jun N-terminal kinase. Clin. Exp. Pharmacol. Physiol. 37, 969-973.
14. Shimizu T, Abe R, Nakamura H, Ohkawara A, Suzuki M, Nishihira J (1999) High expression of macrophage migration inhibitory factor in human melanoma cells and its role in tumor cell growth and angiogenesis. Biochem. Biophys. Res. Commun. 264, 751-758.
15. Bando H, Matsumoto G, Bando M, Muta M, Ogawa T, Funata N et al. (2002) Expression of macrophage migration inhibitory factor in human breast cancer: association with nodal spread. Jpn. J. Cancer Res. 93, 389-396.
16. Meyer-Siegler KL, Bellino MA, Tannenbaum M (2002) Macrophage migration inhibitory factor evaluation compared with prostate specific antigen as a biomarker in patients with prostate carcinoma. Cancer 94, 1449-1456.
17. Markert JM, Fuller CM, Gillespie GY, Bubien JK, McLean LA, Hong RL et al. (2001) Differential gene expression profiling in human brain tumors. Physiol. Genomics 5, 21-33.
18. Han I, Lee MR, Nam KW, Oh JH, Moon KC, Kim HS (2008) Expression of macrophage migration inhibitory factor relates to survival in high-grade osteosarcoma. Clin. Orthop. Relat. Res. 466, 2107-2113.
19. Taylor JA III, Kuchel GA, Hegde P, Voznesensky OS, Claffey K, Tsimikas J et al. (2007) Null mutation for macrophage migration inhibitory factor (MIF) is associated with less aggressive bladder cancer in mice. BMC Cancer 7, 135.
20. Fingerle-Rowson G, Petrenko O (2007) MIF coordinates the cell cycle with DNA damage checkpoints. Lessons from knockout mouse models. Cell Div. 2, 22.
21. Ogawa H, Nishihira J, Sato Y, Kondo M, Takahashi N, Oshima T et al. (2000) An antibody for macrophage migration inhibitory factor suppresses tumour growth and inhibits tumour-associated angiogenesis. Cytokine 12, 309-314.
22. Takahashi N, Nishihira J, Sato Y, Kondo M, Ogawa H, Ohshima T et al. (1998) Involvement of macrophage migration inhibitory factor (MIF) in the mechanism of tumor cell growth. Mol. Med. 4, 707-714.
23. Hagemann T, Robinson SC, Thompson RG, Charles K, Kulbe H, Balkwill FR (2007) Ovarian cancer cell-derived migration inhibitory factor enhances tumor growth, progression, and angiogenesis. Mol. Cancer Ther. 6, 1993-2002.
24. Rendon BE, Roger T, Teneng I, Zhao M, Al-Abed Y, Calandra T et al. (2007) Regulation of human lung adenocarcinoma cell migration and invasion by macrophage migration inhibitory factor. J. Biol. Chem. 282, 29910-29918.
25. Chesney J, Metz C, Bacher M, Peng T, Meinhardt A, Bucala R (1999) An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma. Mol. Med. 5, 181-191.
26. Winner M, Meier J, Zierow S, Rendon BE, Crichlow GV, Riggs R et al. (2008) A novel, macrophage migration inhibitory factor suicide substrate inhibits motility and growth of lung cancer cells. Cancer Res. 68, 7253-7257.
27. Kleemann R, Hausser A, Geiger G, Mischke R, Burger-Kentischer A, Flieger O et al. (2000) Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 408, 211-216.
28. Meyer-Siegler KL, Iczkowski KA, Leng L, Bucala R, Vera PL (2006) Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells. J. Immunol. 177, 8730-8739.
29. Hudson JD, Shoaibi MA, Maestro R, Carnero A, Hannon GJ, Beach DH (1999) A proinflammatory cytokine inhibits p53 tumor suppressor activity. J. Exp. Med. 190, 1375-1382.
30. Talos F, Mena P, Fingerle-Rowson G, Moll U, Petrenko O (2005) MIF loss impairs Myc-induced lymphomagenesis. Cell Death Differ. 12, 1319-1328.
31. Nemajerova A, Moll UM, Petrenko O, Fingerle-Rowson G (2007) Macrophage migration inhibitory factor coordinates DNA damage response with the proteasomal control of the cell cycle. Cell Cycle 6, 1030-1034.
32. Jung H, Seong HA, Ha H (2008) Critical role of cysteine residue 81 of macrophage migration inhibitory factor (MIF) in MIF-induced inhibition of p53 activity. J. Biol. Chem. 283, 20383-20396.
33. Brummelkamp TR, Bernards R, Agami R (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science 296, 550-553.
34. Nemajerova A, Mena P, Fingerle-Rowson G, Moll UM, Petrenko O (2007) Impaired DNA damage checkpoint response in MIF-deficient mice. EMBO J. 26, 987-997.
35. Gustafson WC, Weiss WA (2010) Myc proteins as therapeutic targets. Oncogene 29, 1249-1259.
36. Weber GF (2008) Molecular mechanisms of metastasis. Cancer Lett. 270, 181-190.
37. Lock JG, Wehrle-Haller B, Stromblad S (2008) Cell-matrix adhesion complexes: master control machinery of cell migration. Semin. Cancer Biol. 18, 65-76.
38. Brunton VG, Frame MC (2008) Src and focal adhesion kinase as therapeutic targets in cancer. Curr. Opin. Pharmacol. 8, 427-432.
39. Hussain SP, Harris CC (2007) Inflammation and cancer: an ancient link with novel potentials. Int. J. Cancer 121, 2373-2380.
40. Mitchell RA (2004) Mechanisms and effectors of MIF-dependent promotion of tumourigenesis. Cell. Signal. 16, 13-19.
41. Bucala R, Donnelly SC (2007) Macrophage migration inhibitory factor: a probable link between inflammation and cancer. Immunity 26, 281-285.
42. Liao H, Bucala R, Mitchell RA (2003) Adhesion-dependent signaling by macrophage migration inhibitory factor (MIF). J. Biol. Chem. 278, 76-81.
43. Petrenko O, Moll UM (2005) Macrophage migration inhibitory factor MIF interferes with the Rb-E2F pathway. Mol. Cell 17, 225-236.
44. Swant JD, Rendon BE, Symons M, Mitchell RA (2005) Rho GTPase-dependent signaling is required for macrophage migration inhibitory factor-mediated expression of cyclin D1. J. Biol. Chem. 280, 23066-23072.
45. Nishihira J, Ishibashi T, Fukushima T, Sun B, Sato Y, Todo S (2003) Macrophage migration inhibitory factor (MIF): its potential role in tumor growth and tumor-associated angiogenesis. Ann. N Y Acad. Sci. 995, 171-182.
46. Mitchell RA, Metz CN, Peng T, Bucala R (1999) Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF). Regulatory role in cell proliferation and glucocorticoid action. J. Biol. Chem. 274, 18100-18106.
47. Bach JP, Rinn B, Meyer B, Dodel R, Bacher M (2008) Role of MIF in inflammation and tumorigenesis. Oncology 75, 127-133.